Dysregulation of serotonin and dopamine metabolism, mediated by disruptions in the tryptophan-kynurenine pathway and tyrosine hydroxylase (TH) activity, contributes to neurotransmitter imbalances associated with depression. The gene discussed is TH; the disease is depressive symptom measurement.